Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia.

Lo Coco F, Diverio D, Falini B, Biondi A, Nervi C, Pelicci PG.

Blood. 1999 Jul 1;94(1):12-22. Review. No abstract available.

2.

Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia.

Melnick A, Licht JD.

Blood. 1999 May 15;93(10):3167-215. Review. No abstract available.

3.

Proto-oncogene PML controls genes devoted to MHC class I antigen presentation.

Zheng P, Guo Y, Niu Q, Levy DE, Dyck JA, Lu S, Sheiman LA, Liu Y.

Nature. 1998 Nov 26;396(6709):373-6.

PMID:
9845074
4.

Light scatter and immunophenotypic characteristics of blast cells in typical acute promyelocytic leukemia and its variant.

Piedras J, López-Karpovitch X, Cárdenas R.

Cytometry. 1998 Aug 1;32(4):286-90.

PMID:
9701397
5.

Role of PML in cell growth and the retinoic acid pathway.

Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C, Grosveld F, Pandolfi PP.

Science. 1998 Mar 6;279(5356):1547-51.

6.

The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein.

Alcalay M, Tomassoni L, Colombo E, Stoldt S, Grignani F, Fagioli M, Szekely L, Helin K, Pelicci PG.

Mol Cell Biol. 1998 Feb;18(2):1084-93.

7.

Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.

Grimwade D, Gorman P, Duprez E, Howe K, Langabeer S, Oliver F, Walker H, Culligan D, Waters J, Pomfret M, Goldstone A, Burnett A, Freemont P, Sheer D, Solomon E.

Blood. 1997 Dec 15;90(12):4876-85.

8.

Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein.

Li JY, English MA, Ball HJ, Yeyati PL, Waxman S, Licht JD.

J Biol Chem. 1997 Sep 5;272(36):22447-55.

9.

Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.

Gallagher RE, Willman CL, Slack JL, Andersen JW, Li YP, Viswanatha D, Bloomfield CD, Appelbaum FR, Schiffer CA, Tallman MS, Wiernik PH.

Blood. 1997 Aug 15;90(4):1656-63.

10.

RAR alpha1/RAR alpha2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative study.

Li YP, Andersen J, Zelent A, Rao S, Paietta E, Tallman MS, Wiernik PH, Gallagher RE.

Blood. 1997 Jul 1;90(1):306-12.

11.

Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.

He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G, Pandolfi PP.

Proc Natl Acad Sci U S A. 1997 May 13;94(10):5302-7.

12.

A PMLRARalpha transgene initiates murine acute promyelocytic leukemia.

Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG, Atwater S, Bishop JM.

Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2551-6.

13.
14.
15.

Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party.

Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H, Swirsky D, Wheatley K, Goldstone A, Burnett A, Solomon E.

Br J Haematol. 1996 Sep;94(3):557-73.

PMID:
8790159
16.

Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia.

Licht JD, Shaknovich R, English MA, Melnick A, Li JY, Reddy JC, Dong S, Chen SJ, Zelent A, Waxman S.

Oncogene. 1996 Jan 18;12(2):323-36.

PMID:
8570209
17.

The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.

Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ.

Blood. 1996 Feb 1;87(3):882-6.

18.

CD34: structure, biology, and clinical utility.

Krause DS, Fackler MJ, Civin CI, May WS.

Blood. 1996 Jan 1;87(1):1-13. Review. No abstract available.

19.

Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation.

Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B.

Cell. 1993 Feb 12;72(3):309-24.

PMID:
8381715
20.

Early myeloid cell-specific expression of the human cathepsin G gene in transgenic mice.

Grisolano JL, Sclar GM, Ley TJ.

Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8989-93.

Supplemental Content

Support Center